<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>A promising new medicine against heart disease fails unexpectedly — Live Feed</title><link>https://www.live-feeds.com/feed/a-promising-new-medicine-against-heart-disease-fails-unexpectedly</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/a-promising-new-medicine-against-heart-disease-fails-unexpectedly/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Heart Drug Pelacarsen Fails Major Clinical Trial</title><link>https://www.live-feeds.com/feed/a-promising-new-medicine-against-heart-disease-fails-unexpectedly</link><guid isPermaLink="false">https://www.live-feeds.com/feed/a-promising-new-medicine-against-heart-disease-fails-unexpectedly#u198804</guid><pubDate>Fri, 13 Nov 2026 13:15:44 +0000</pubDate><description>An experimental heart disease drug called pelacarsen failed a crucial clinical trial despite successfully cutting levels of lipoprotein(a) in the blood by seventy-eight percent. Medical professionals held high expectations that the treatment would serve as a major advance in preventing strokes, heart attacks, and cardiovascular deaths. Instead, the medication showed zero benefit and made no difference in preventing cardiovascular complications or saving patients&amp;#039; lives. Following the disappointing results, Novartis is largely abandoning the experimental drug, which analysts previously con</description></item>
</channel></rss>